News - ANAVEX

View all Alzheimer's Disease Anavex2-73 Events News Releases PIPELINE Press Uncategorized

Ladenburg Thalmann 2017 Healthcare Conference Sept 26 3:30pm

Anavex®Life Sciences Issued New U.S. Patent for Composition of Matter Covering ANAVEX®2-73

CNS Diseases Summit 2017 Sept 11-12

Anavex Reports Fiscal Third Quarter 2017 Financial Results

Anavex Life Sciences Appoints Distinguished Researcher in Neurology and Epilepsy to Scientific Advisory Board

2017 Bio International Convention June 19-22

Anavex Life Sciences to Present at Jefferies 2017 Global Healthcare Conference

Jefferies 2017 Global Healthcare Conference June 6-9

Anavex Life Sciences Reports New Data for ANAVEX 2-73 in Neurodevelopmental Disorders Including Angelman Syndrome − Data Presented at Antiepileptic Drug Trials XIV 2017 Conference

Anavex Life Sciences Reports New Data for ANAVEX 2-73 in Neurodevelopmental Disorders Including Angelman Syndrome − Data Presented at Antiepileptic Drug Trials XIV 2017 Conference −